Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2000 | 12-1999 | 09-1999 | 06-1999 | 03-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -890 | -5,220 | -4,250 | -3,020 | -1,520 |
| Depreciation Amortization | 30 | 110 | 80 | 50 | 20 |
| Other Working Capital | -50 | -1,340 | -670 | -350 | 150 |
| Other Operating Activity | 10 | 50 | 50 | 50 | 60 |
| Operating Cash Flow | $-900 | $-6,400 | $-4,790 | $-3,270 | $-1,290 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -40 | -150 | -30 | -30 | -20 |
| Other Investing Activity | -8,860 | 700 | 1,730 | 3,540 | 510 |
| Investing Cash Flow | $-8,900 | $550 | $1,700 | $3,510 | $490 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -1 | -1 | -1 | -1 | -1 |
| Other Financing Activity | 12,591 | 3,071 | 3,001 | 8 | -19 |
| Financing Cash Flow | $12,590 | $3,070 | $3,000 | $7 | $-20 |
| Beginning Cash Position | 200 | 2,980 | 2,980 | 2,980 | 2,980 |
| End Cash Position | 2,990 | 200 | 2,890 | 3,220 | 2,150 |
| Net Cash Flow | $2,780 | $-2,770 | $-80 | $240 | $-820 |
| Free Cash Flow | |||||
| Operating Cash Flow | -900 | -6,400 | -4,790 | -3,270 | -1,290 |
| Free Cash Flow | -900 | -6,400 | -4,790 | -3,270 | -1,290 |